Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
Neuroscience
|
May 5, 2007
P2X7-related modulation of pathological nociception in rats
S McGaraughty, K L Chu, M T Namovic, et al.
The Journal of Surgical Research
|
July 3, 2022
A Multicenter Analysis of the Early Impact of COVID-19 on Junior Resident Operative Case Volume
Benjamin Kramer, Gilman Plitt, Judith C French, et al.
Pain
|
March 16, 2011
Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation
Jun Chen, Shailen K Joshi, Stanley DiDomenico, et al.
Current Pharmaceutical Design
|
April 10, 1999
Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseases
K W Mollison, T A Fey, D M Gauvin, et al.
Pain
|
January 13, 2009
Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia
Prisca Honore, Prasant Chandran, Gricelda Hernandez, et al.
American Journal of Surgery
|
August 19, 2019
Factors associated with general surgery residents' decisions regarding fellowship and subspecialty stratified by burnout and quality of life
Natalie C McClintock, Kelsey E Gray, Angela L Neville, et al.
American Journal of Surgery
|
January 3, 2021
A multi-institutional study assessing general surgery faculty teaching evaluations
Adam D Shellito, Christian de Virgilio, Amy H Kaji, et al.
Bioorganic & Medicinal Chemistry
|
May 27, 2008
Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain
Irene Drizin, Robert J Gregg, Marc J C Scanio, et al.
Journal of Medicinal Chemistry
|
August 8, 2014
Discovery of (R)-1-(7-chloro-2,2-bis(fluoromethyl)chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea (A-1165442): a temperature-neutral transient receptor potential vanilloid-1 (TRPV1) antagonist with analgesic efficacy
Eric A Voight, Arthur R Gomtsyan, Jerome F Daanen, et al.
Journal of Medicinal Chemistry
|
April 15, 2016
Synthesis and Pharmacology of (Pyridin-2-yl)methanol Derivatives as Novel and Selective Transient Receptor Potential Vanilloid 3 Antagonists
Arthur Gomtsyan, Robert G Schmidt, Erol K Bayburt, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
Neuroscience
|
May 5, 2007
P2X7-related modulation of pathological nociception in rats
S McGaraughty, K L Chu, M T Namovic, et al.
The Journal of Surgical Research
|
July 3, 2022
A Multicenter Analysis of the Early Impact of COVID-19 on Junior Resident Operative Case Volume
Benjamin Kramer, Gilman Plitt, Judith C French, et al.
Pain
|
March 16, 2011
Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation
Jun Chen, Shailen K Joshi, Stanley DiDomenico, et al.
Current Pharmaceutical Design
|
April 10, 1999
Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseases
K W Mollison, T A Fey, D M Gauvin, et al.
Pain
|
January 13, 2009
Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia
Prisca Honore, Prasant Chandran, Gricelda Hernandez, et al.
American Journal of Surgery
|
August 19, 2019
Factors associated with general surgery residents' decisions regarding fellowship and subspecialty stratified by burnout and quality of life
Natalie C McClintock, Kelsey E Gray, Angela L Neville, et al.
American Journal of Surgery
|
January 3, 2021
A multi-institutional study assessing general surgery faculty teaching evaluations
Adam D Shellito, Christian de Virgilio, Amy H Kaji, et al.
Bioorganic & Medicinal Chemistry
|
May 27, 2008
Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain
Irene Drizin, Robert J Gregg, Marc J C Scanio, et al.
Journal of Medicinal Chemistry
|
August 8, 2014
Discovery of (R)-1-(7-chloro-2,2-bis(fluoromethyl)chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea (A-1165442): a temperature-neutral transient receptor potential vanilloid-1 (TRPV1) antagonist with analgesic efficacy
Eric A Voight, Arthur R Gomtsyan, Jerome F Daanen, et al.
Journal of Medicinal Chemistry
|
April 15, 2016
Synthesis and Pharmacology of (Pyridin-2-yl)methanol Derivatives as Novel and Selective Transient Receptor Potential Vanilloid 3 Antagonists
Arthur Gomtsyan, Robert G Schmidt, Erol K Bayburt, et al.
Page
of 11